
Sign up to save your podcasts
Or
FTX Testimony and Moderna's New Drug (Podcast)Mike McGlone, Senior Commodity Strategist with Bloomberg Intelligence, and Nathan Dean, Senior Policy Analyst, US and Latin America with Bloomberg Intelligence, and Katie Greifeld, cross asset reporter with Bloomberg News, join the show to discuss outlook for crypto coins and crypto policy in DC ahead of the testimony of FTX's new CEO. Moderna CEO Stephane Bancel discusses the company's skin cancer drug breakthrough. Annie Massa, cross asset reporter with Bloomberg News, and Barry Ritholtz, host of Bloomberg's "Masters in Business," join to discuss the FTX testimony on Capitol Hill. Hosted by Paul Sweeney and Matt Miller.
See omnystudio.com/listener for privacy information.
3.8
372372 ratings
FTX Testimony and Moderna's New Drug (Podcast)Mike McGlone, Senior Commodity Strategist with Bloomberg Intelligence, and Nathan Dean, Senior Policy Analyst, US and Latin America with Bloomberg Intelligence, and Katie Greifeld, cross asset reporter with Bloomberg News, join the show to discuss outlook for crypto coins and crypto policy in DC ahead of the testimony of FTX's new CEO. Moderna CEO Stephane Bancel discusses the company's skin cancer drug breakthrough. Annie Massa, cross asset reporter with Bloomberg News, and Barry Ritholtz, host of Bloomberg's "Masters in Business," join to discuss the FTX testimony on Capitol Hill. Hosted by Paul Sweeney and Matt Miller.
See omnystudio.com/listener for privacy information.
1,179 Listeners
440 Listeners
2,162 Listeners
979 Listeners
1,810 Listeners
965 Listeners
189 Listeners
1,016 Listeners
178 Listeners
64 Listeners
1,278 Listeners
65 Listeners
75 Listeners
31 Listeners
57 Listeners
4 Listeners
56 Listeners
2 Listeners
53 Listeners
7 Listeners
194 Listeners
12 Listeners
232 Listeners
74 Listeners
72 Listeners
19 Listeners
49 Listeners
83 Listeners
382 Listeners
48 Listeners